Faeth Therapeutics, Inc. Common Stock (FTH)
Since Aug 04, 2021, Faeth Therapeutics, Inc. Common Stock (FTH) has reported earnings 20 times. On average the shares move ±6.30% post-earnings, with a positive reaction 35.0% of the time. Its largest post-earnings gain was +20.54% (Mar 28, 2025) and its largest decline was -14.93% (Nov 14, 2024). The next earnings report is predicted for 2026-08-06 (estimated).
Earnings reactions
How FTH moved on each past earnings report.
Earnings Impact
Total Earnings
20
Avg Abs. Movement
±6.30%
Positive %
35.0%
Negative %
65.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 15, 2026 | ☽ POST | -3.27% | — |
| Mar 30, 2026 | ☀ PRE | -9.29% | open_in_new |
| Nov 14, 2025 | ☀ PRE | -5.93% | open_in_new |
| Aug 05, 2025 | ☀ PRE | +0% | open_in_new |
Earnings Count
20
Total earnings in dataset
Avg Abs. Movement
±6.30%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260723 | open_in_new SEC.gov |
| 4 | 20260723 | open_in_new SEC.gov |
| 8-K | 20260723 | open_in_new SEC.gov |
| 4 | 20260701 | open_in_new SEC.gov |
| 4 | 20260626 | open_in_new SEC.gov |
| 4 | 20260624 | open_in_new SEC.gov |
| 4 | 20260624 | open_in_new SEC.gov |
| 3 | 20260623 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260623 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260623 | open_in_new SEC.gov |
Frequently asked about FTH earnings
When does Faeth Therapeutics, Inc. Common Stock report earnings next? expand_more
Faeth Therapeutics, Inc. Common Stock (FTH)'s next earnings date is estimated for 2026-08-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does FTH stock move after earnings? expand_more
Over 20 reports, FTH has moved an average of ±6.30% the session after earnings, closing higher 35.0% of the time.
What was FTH's biggest post-earnings move? expand_more
FTH's largest post-earnings gain on record was +20.54% on Mar 28, 2025, and its largest decline was -14.93% on Nov 14, 2024.
Where can I find Faeth Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of Faeth Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-08-05
- Allegiant Travel CO (ALGT) earnings 2026-08-03
- AbCellera Biologics Inc. Common Shares (ABCL) earnings 2026-08-05
- Airbnb (ABNB) earnings 2026-08-05
- Arbutus Biopharma Corp (ABUS) earnings 2026-08-03
- Arcosa, Inc. (ACA) earnings 2026-08-04
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-08-05
- ACCO BRANDS Corp (ACCO) earnings 2026-08-04